# UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON: Elucidating Novel Immunomodulatory Mechanisms of Neonatal Fc Receptor Blockade by Efgartigimod in a T Cell-Mediated Demyelinating Neuropathy Model

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON |
| Location | HOUSTON, TX |
| Project | Elucidating Novel Immunomodulatory Mechanisms of Neonatal Fc Receptor Blockade by Efgartigimod in a T Cell-Mediated Demyelinating Neuropathy Model |
| Project number | 1R21NS146824-01A1 |
| Mechanism | R21 |
| Institute | National Institute of Neurological Disorders and Stroke |
| Award | $234,000 |
| Awarded | 2026-09-03 |
| Project period | 2026-09-03 to 2028-08-31 |
| UEI | ZUFBNVZ587D4 |

## Why this score
- Award of $234,000.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11453598). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.